Ali, Robin R.
Guy's Hospital,
United Kingdom
2025 Rank: 202169
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biotechnology
Rank in SubField 1: 990 out of 81681 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 202169 | 227709 |
| Total Cites | 812 | 898 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 13 | 13 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 350 | 371 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 557 | 590 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.52 |
| Self-Citation Percentage |
9.58%
|
|
Ali, Robin R.
King's College London,
United Kingdom
2024 Rank: 163533
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biotechnology
Rank in SubField 1: 827 out of 77284 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 163533 | 182783 |
| Total Cites | 897 | 970 |
| H-index | 15 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 11 | 11 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 400 | 427 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 598 | 631 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.54 |
| Self-Citation Percentage |
7.53%
|
|
Ali, Robin R.
UCL Institute of Ophthalmology,
United Kingdom
2023 Rank: 121340
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biotechnology
Rank in SubField 1: 676 out of 72989 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121340 | 124893 |
| Total Cites | 961 | 1043 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 23 | 23 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 464 | 493 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 605 | 651 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.60 |
| Self-Citation Percentage |
7.86%
|
|
Ali, Robin R.
UCL Institute of Ophthalmology,
United Kingdom
2022 Rank: 103641
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biotechnology
Rank in SubField 1: 579 out of 69077 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103641 | 108531 |
| Total Cites | 1136 | 1269 |
| H-index | 15 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 21 | 21 |
| Number of Single+First+Last Authored Papers | 102 | 102 |
| Total Cites to Single+First+Last Authored Papers | 581 | 624 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 696 | 749 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.69 |
| Self-Citation Percentage |
10.48%
|
|
Ali, Robin R.
UCL Institute of Ophthalmology,
United Kingdom
2021 Rank: 99706
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biotechnology
Rank in SubField 1: 552 out of 65331 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 99706 | 105410 |
| Total Cites | 1540 | 1763 |
| H-index | 18 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 31 | 31 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 814 | 900 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 970 | 1052 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.68 |
| Self-Citation Percentage |
12.65%
|
|
Ali, Robin R.
UCL Institute of Ophthalmology,
United Kingdom
2020 Rank: 81582
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biotechnology
Rank in SubField 1: 407 out of 52338 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81582 | 89053 |
| Total Cites | 1167 | 1293 |
| H-index | 16 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 22 | 22 |
| Number of Single+First+Last Authored Papers | 97 | 97 |
| Total Cites to Single+First+Last Authored Papers | 632 | 679 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 690 | 739 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.75 |
| Self-Citation Percentage |
9.74%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.